Article Information
History
- May 5, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Bruce K. Patterson1,^,
- Harish Seethamraju2,
- Kush Dhody3,
- Michael J. Corley4,
- Kazem Kazempour3,
- Jay Lalezari5,
- Alina P.S. Pang6,
- Christopher Sugai6,
- Edgar B. Francisco1,
- Amruta Pise1,
- Hallison Rodrigues1,
- Mathew Ryou1,
- Helen L. Wu7,
- Gabriela M. Webb7,
- Byung S. Park7,
- Scott Kelly8,
- Nader Pourhassan8,
- Alena Lelic9,
- Lama Kdouh9,
- Monica Herrera10,
- Eric Hall10,
- Enver Aklin2,
- Lishomwa C. Ndhlovu4,* and
- Jonah B. Sacha7,*
- 1IncellDX, Menlo Park, CA, USA
- 2Montefiore Medical Center, New York, NY, USA
- 3Amarex Clinical Research LLC, Germantown, MD, USA
- 4Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA
- 5Quest Clinical Research, San Francisco, California, USA
- 6University of Hawaii, Honolulu, HI, USA
- 7Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, USA
- 8CytoDyn Inc., Vancouver, WA, USA
- 9Beckman Coulter, Miami, FL, USA
- 10Bio-Rad, Pleasanton, CA, USA
- ↵^Corresponding author: Bruce K. Patterson, MD, IncellDx, Inc, 1541 Industrial Road, San Carlos, CA 94070, Tel: +1.650.777.7630, Fax: +1.650.587.1528 brucep{at}incelldx.com
Posted May 05, 2020.
Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19
